Global Pharmaceutical Peptides Services Market Growth (Status and Outlook) 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
The global market for Pharmaceutical Peptides Services is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Pharmaceutical Peptides Services market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Pharmaceutical Peptides Services market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Pharmaceutical Peptides Services market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Pharmaceutical Peptides Services market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Pharmaceutical Peptides Services players cover Creative Peptides, AmbioPharm, 3B Pharmaceuticals, ISSAR Pharma and Peptide Institute, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Pharmaceutical Peptides Services market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Pharmaceutical Peptides Services market, with both quantitative and qualitative data, to help readers understand how the Pharmaceutical Peptides Services market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Pharmaceutical Peptides Services market and forecasts the market size by Type (Peptide Drug Discovery, Peptide Drug Bioconjugations and Peptide Lead Optimization), by Application (Enterprise and Research Institute.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Chapter 1: Scope of Pharmaceutical Peptides Services, Research Methodology, etc.
Chapter 2: Executive Summary, global Pharmaceutical Peptides Services market size and CAGR, Pharmaceutical Peptides Services market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Pharmaceutical Peptides Services revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Pharmaceutical Peptides Services revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Pharmaceutical Peptides Services market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Creative Peptides, AmbioPharm, 3B Pharmaceuticals, ISSAR Pharma, Peptide Institute, WuXi AppTec, JPT Peptide Technologies, CPC Scientific and Red Glead Discovery, etc.
Chapter 14: Research Findings and Conclusion
The global market for Pharmaceutical Peptides Services is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Pharmaceutical Peptides Services market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Pharmaceutical Peptides Services market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Pharmaceutical Peptides Services market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Pharmaceutical Peptides Services market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Pharmaceutical Peptides Services players cover Creative Peptides, AmbioPharm, 3B Pharmaceuticals, ISSAR Pharma and Peptide Institute, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Pharmaceutical Peptides Services market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Pharmaceutical Peptides Services market, with both quantitative and qualitative data, to help readers understand how the Pharmaceutical Peptides Services market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Pharmaceutical Peptides Services market and forecasts the market size by Type (Peptide Drug Discovery, Peptide Drug Bioconjugations and Peptide Lead Optimization), by Application (Enterprise and Research Institute.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
- Peptide Drug Discovery
- Peptide Drug Bioconjugations
- Peptide Lead Optimization
- Formulation Development
- Peptide Drug Screening Service
- Total Peptide Library Construction Technology
- Other
- Enterprise
- Research Institute
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Creative Peptides
- AmbioPharm
- 3B Pharmaceuticals
- ISSAR Pharma
- Peptide Institute
- WuXi AppTec
- JPT Peptide Technologies
- CPC Scientific
- Red Glead Discovery
- Eurofins Scientific
- Bio-Synthesis
- Bio Basic
- CordenPharma
Chapter 1: Scope of Pharmaceutical Peptides Services, Research Methodology, etc.
Chapter 2: Executive Summary, global Pharmaceutical Peptides Services market size and CAGR, Pharmaceutical Peptides Services market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Pharmaceutical Peptides Services revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Pharmaceutical Peptides Services revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Pharmaceutical Peptides Services market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Creative Peptides, AmbioPharm, 3B Pharmaceuticals, ISSAR Pharma, Peptide Institute, WuXi AppTec, JPT Peptide Technologies, CPC Scientific and Red Glead Discovery, etc.
Chapter 14: Research Findings and Conclusion
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pharmaceutical Peptides Services Market Size 2017-2028
2.1.2 Pharmaceutical Peptides Services Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Pharmaceutical Peptides Services Segment by Type
2.2.1 Peptide Drug Discovery
2.2.2 Peptide Drug Bioconjugations
2.2.3 Peptide Lead Optimization
2.2.4 Formulation Development
2.2.5 Peptide Drug Screening Service
2.2.6 Total Peptide Library Construction Technology
2.2.7 Other
2.3 Pharmaceutical Peptides Services Market Size by Type
2.3.1 Pharmaceutical Peptides Services Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Pharmaceutical Peptides Services Market Size Market Share by Type (2017-2022)
2.4 Pharmaceutical Peptides Services Segment by Application
2.4.1 Enterprise
2.4.2 Research Institute
2.5 Pharmaceutical Peptides Services Market Size by Application
2.5.1 Pharmaceutical Peptides Services Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Pharmaceutical Peptides Services Market Size Market Share by Application (2017-2022)
3 PHARMACEUTICAL PEPTIDES SERVICES MARKET SIZE BY PLAYER
3.1 Pharmaceutical Peptides Services Market Size Market Share by Players
3.1.1 Global Pharmaceutical Peptides Services Revenue by Players (2020-2022)
3.1.2 Global Pharmaceutical Peptides Services Revenue Market Share by Players (2020-2022)
3.2 Global Pharmaceutical Peptides Services Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PHARMACEUTICAL PEPTIDES SERVICES BY REGIONS
4.1 Pharmaceutical Peptides Services Market Size by Regions (2017-2022)
4.2 Americas Pharmaceutical Peptides Services Market Size Growth (2017-2022)
4.3 APAC Pharmaceutical Peptides Services Market Size Growth (2017-2022)
4.4 Europe Pharmaceutical Peptides Services Market Size Growth (2017-2022)
4.5 Middle East & Africa Pharmaceutical Peptides Services Market Size Growth (2017-2022)
5 AMERICAS
5.1 Americas Pharmaceutical Peptides Services Market Size by Country (2017-2022)
5.2 Americas Pharmaceutical Peptides Services Market Size by Type (2017-2022)
5.3 Americas Pharmaceutical Peptides Services Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pharmaceutical Peptides Services Market Size by Region (2017-2022)
6.2 APAC Pharmaceutical Peptides Services Market Size by Type (2017-2022)
6.3 APAC Pharmaceutical Peptides Services Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Pharmaceutical Peptides Services by Country (2017-2022)
7.2 Europe Pharmaceutical Peptides Services Market Size by Type (2017-2022)
7.3 Europe Pharmaceutical Peptides Services Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pharmaceutical Peptides Services by Region (2017-2022)
8.2 Middle East & Africa Pharmaceutical Peptides Services Market Size by Type (2017-2022)
8.3 Middle East & Africa Pharmaceutical Peptides Services Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PHARMACEUTICAL PEPTIDES SERVICES MARKET FORECAST
10.1 Global Pharmaceutical Peptides Services Forecast by Regions (2023-2028)
10.1.1 Global Pharmaceutical Peptides Services Forecast by Regions (2023-2028)
10.1.2 Americas Pharmaceutical Peptides Services Forecast
10.1.3 APAC Pharmaceutical Peptides Services Forecast
10.1.4 Europe Pharmaceutical Peptides Services Forecast
10.1.5 Middle East & Africa Pharmaceutical Peptides Services Forecast
10.2 Americas Pharmaceutical Peptides Services Forecast by Country (2023-2028)
10.2.1 United States Pharmaceutical Peptides Services Market Forecast
10.2.2 Canada Pharmaceutical Peptides Services Market Forecast
10.2.3 Mexico Pharmaceutical Peptides Services Market Forecast
10.2.4 Brazil Pharmaceutical Peptides Services Market Forecast
10.3 APAC Pharmaceutical Peptides Services Forecast by Region (2023-2028)
10.3.1 China Pharmaceutical Peptides Services Market Forecast
10.3.2 Japan Pharmaceutical Peptides Services Market Forecast
10.3.3 Korea Pharmaceutical Peptides Services Market Forecast
10.3.4 Southeast Asia Pharmaceutical Peptides Services Market Forecast
10.3.5 India Pharmaceutical Peptides Services Market Forecast
10.3.6 Australia Pharmaceutical Peptides Services Market Forecast
10.4 Europe Pharmaceutical Peptides Services Forecast by Country (2023-2028)
10.4.1 Germany Pharmaceutical Peptides Services Market Forecast
10.4.2 France Pharmaceutical Peptides Services Market Forecast
10.4.3 UK Pharmaceutical Peptides Services Market Forecast
10.4.4 Italy Pharmaceutical Peptides Services Market Forecast
10.4.5 Russia Pharmaceutical Peptides Services Market Forecast
10.5 Middle East & Africa Pharmaceutical Peptides Services Forecast by Region (2023-2028)
10.5.1 Egypt Pharmaceutical Peptides Services Market Forecast
10.5.2 South Africa Pharmaceutical Peptides Services Market Forecast
10.5.3 Israel Pharmaceutical Peptides Services Market Forecast
10.5.4 Turkey Pharmaceutical Peptides Services Market Forecast
10.5.5 GCC Countries Pharmaceutical Peptides Services Market Forecast
10.6 Global Pharmaceutical Peptides Services Forecast by Type (2023-2028)
10.7 Global Pharmaceutical Peptides Services Forecast by Application (2023-2028)
11 KEY PLAYERS ANALYSIS
11.1 Creative Peptides
11.1.1 Creative Peptides Company Information
11.1.2 Creative Peptides Pharmaceutical Peptides Services Product Offered
11.1.3 Creative Peptides Pharmaceutical Peptides Services Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Creative Peptides Main Business Overview
11.1.5 Creative Peptides Latest Developments
11.2 AmbioPharm
11.2.1 AmbioPharm Company Information
11.2.2 AmbioPharm Pharmaceutical Peptides Services Product Offered
11.2.3 AmbioPharm Pharmaceutical Peptides Services Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 AmbioPharm Main Business Overview
11.2.5 AmbioPharm Latest Developments
11.3 3B Pharmaceuticals
11.3.1 3B Pharmaceuticals Company Information
11.3.2 3B Pharmaceuticals Pharmaceutical Peptides Services Product Offered
11.3.3 3B Pharmaceuticals Pharmaceutical Peptides Services Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 3B Pharmaceuticals Main Business Overview
11.3.5 3B Pharmaceuticals Latest Developments
11.4 ISSAR Pharma
11.4.1 ISSAR Pharma Company Information
11.4.2 ISSAR Pharma Pharmaceutical Peptides Services Product Offered
11.4.3 ISSAR Pharma Pharmaceutical Peptides Services Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 ISSAR Pharma Main Business Overview
11.4.5 ISSAR Pharma Latest Developments
11.5 Peptide Institute
11.5.1 Peptide Institute Company Information
11.5.2 Peptide Institute Pharmaceutical Peptides Services Product Offered
11.5.3 Peptide Institute Pharmaceutical Peptides Services Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Peptide Institute Main Business Overview
11.5.5 Peptide Institute Latest Developments
11.6 WuXi AppTec
11.6.1 WuXi AppTec Company Information
11.6.2 WuXi AppTec Pharmaceutical Peptides Services Product Offered
11.6.3 WuXi AppTec Pharmaceutical Peptides Services Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 WuXi AppTec Main Business Overview
11.6.5 WuXi AppTec Latest Developments
11.7 JPT Peptide Technologies
11.7.1 JPT Peptide Technologies Company Information
11.7.2 JPT Peptide Technologies Pharmaceutical Peptides Services Product Offered
11.7.3 JPT Peptide Technologies Pharmaceutical Peptides Services Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 JPT Peptide Technologies Main Business Overview
11.7.5 JPT Peptide Technologies Latest Developments
11.8 CPC Scientific
11.8.1 CPC Scientific Company Information
11.8.2 CPC Scientific Pharmaceutical Peptides Services Product Offered
11.8.3 CPC Scientific Pharmaceutical Peptides Services Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 CPC Scientific Main Business Overview
11.8.5 CPC Scientific Latest Developments
11.9 Red Glead Discovery
11.9.1 Red Glead Discovery Company Information
11.9.2 Red Glead Discovery Pharmaceutical Peptides Services Product Offered
11.9.3 Red Glead Discovery Pharmaceutical Peptides Services Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Red Glead Discovery Main Business Overview
11.9.5 Red Glead Discovery Latest Developments
11.10 Eurofins Scientific
11.10.1 Eurofins Scientific Company Information
11.10.2 Eurofins Scientific Pharmaceutical Peptides Services Product Offered
11.10.3 Eurofins Scientific Pharmaceutical Peptides Services Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Eurofins Scientific Main Business Overview
11.10.5 Eurofins Scientific Latest Developments
11.11 Bio-Synthesis
11.11.1 Bio-Synthesis Company Information
11.11.2 Bio-Synthesis Pharmaceutical Peptides Services Product Offered
11.11.3 Bio-Synthesis Pharmaceutical Peptides Services Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Bio-Synthesis Main Business Overview
11.11.5 Bio-Synthesis Latest Developments
11.12 Bio Basic
11.12.1 Bio Basic Company Information
11.12.2 Bio Basic Pharmaceutical Peptides Services Product Offered
11.12.3 Bio Basic Pharmaceutical Peptides Services Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Bio Basic Main Business Overview
11.12.5 Bio Basic Latest Developments
11.13 CordenPharma
11.13.1 CordenPharma Company Information
11.13.2 CordenPharma Pharmaceutical Peptides Services Product Offered
11.13.3 CordenPharma Pharmaceutical Peptides Services Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 CordenPharma Main Business Overview
11.13.5 CordenPharma Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pharmaceutical Peptides Services Market Size 2017-2028
2.1.2 Pharmaceutical Peptides Services Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Pharmaceutical Peptides Services Segment by Type
2.2.1 Peptide Drug Discovery
2.2.2 Peptide Drug Bioconjugations
2.2.3 Peptide Lead Optimization
2.2.4 Formulation Development
2.2.5 Peptide Drug Screening Service
2.2.6 Total Peptide Library Construction Technology
2.2.7 Other
2.3 Pharmaceutical Peptides Services Market Size by Type
2.3.1 Pharmaceutical Peptides Services Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Pharmaceutical Peptides Services Market Size Market Share by Type (2017-2022)
2.4 Pharmaceutical Peptides Services Segment by Application
2.4.1 Enterprise
2.4.2 Research Institute
2.5 Pharmaceutical Peptides Services Market Size by Application
2.5.1 Pharmaceutical Peptides Services Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Pharmaceutical Peptides Services Market Size Market Share by Application (2017-2022)
3 PHARMACEUTICAL PEPTIDES SERVICES MARKET SIZE BY PLAYER
3.1 Pharmaceutical Peptides Services Market Size Market Share by Players
3.1.1 Global Pharmaceutical Peptides Services Revenue by Players (2020-2022)
3.1.2 Global Pharmaceutical Peptides Services Revenue Market Share by Players (2020-2022)
3.2 Global Pharmaceutical Peptides Services Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PHARMACEUTICAL PEPTIDES SERVICES BY REGIONS
4.1 Pharmaceutical Peptides Services Market Size by Regions (2017-2022)
4.2 Americas Pharmaceutical Peptides Services Market Size Growth (2017-2022)
4.3 APAC Pharmaceutical Peptides Services Market Size Growth (2017-2022)
4.4 Europe Pharmaceutical Peptides Services Market Size Growth (2017-2022)
4.5 Middle East & Africa Pharmaceutical Peptides Services Market Size Growth (2017-2022)
5 AMERICAS
5.1 Americas Pharmaceutical Peptides Services Market Size by Country (2017-2022)
5.2 Americas Pharmaceutical Peptides Services Market Size by Type (2017-2022)
5.3 Americas Pharmaceutical Peptides Services Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pharmaceutical Peptides Services Market Size by Region (2017-2022)
6.2 APAC Pharmaceutical Peptides Services Market Size by Type (2017-2022)
6.3 APAC Pharmaceutical Peptides Services Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Pharmaceutical Peptides Services by Country (2017-2022)
7.2 Europe Pharmaceutical Peptides Services Market Size by Type (2017-2022)
7.3 Europe Pharmaceutical Peptides Services Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pharmaceutical Peptides Services by Region (2017-2022)
8.2 Middle East & Africa Pharmaceutical Peptides Services Market Size by Type (2017-2022)
8.3 Middle East & Africa Pharmaceutical Peptides Services Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PHARMACEUTICAL PEPTIDES SERVICES MARKET FORECAST
10.1 Global Pharmaceutical Peptides Services Forecast by Regions (2023-2028)
10.1.1 Global Pharmaceutical Peptides Services Forecast by Regions (2023-2028)
10.1.2 Americas Pharmaceutical Peptides Services Forecast
10.1.3 APAC Pharmaceutical Peptides Services Forecast
10.1.4 Europe Pharmaceutical Peptides Services Forecast
10.1.5 Middle East & Africa Pharmaceutical Peptides Services Forecast
10.2 Americas Pharmaceutical Peptides Services Forecast by Country (2023-2028)
10.2.1 United States Pharmaceutical Peptides Services Market Forecast
10.2.2 Canada Pharmaceutical Peptides Services Market Forecast
10.2.3 Mexico Pharmaceutical Peptides Services Market Forecast
10.2.4 Brazil Pharmaceutical Peptides Services Market Forecast
10.3 APAC Pharmaceutical Peptides Services Forecast by Region (2023-2028)
10.3.1 China Pharmaceutical Peptides Services Market Forecast
10.3.2 Japan Pharmaceutical Peptides Services Market Forecast
10.3.3 Korea Pharmaceutical Peptides Services Market Forecast
10.3.4 Southeast Asia Pharmaceutical Peptides Services Market Forecast
10.3.5 India Pharmaceutical Peptides Services Market Forecast
10.3.6 Australia Pharmaceutical Peptides Services Market Forecast
10.4 Europe Pharmaceutical Peptides Services Forecast by Country (2023-2028)
10.4.1 Germany Pharmaceutical Peptides Services Market Forecast
10.4.2 France Pharmaceutical Peptides Services Market Forecast
10.4.3 UK Pharmaceutical Peptides Services Market Forecast
10.4.4 Italy Pharmaceutical Peptides Services Market Forecast
10.4.5 Russia Pharmaceutical Peptides Services Market Forecast
10.5 Middle East & Africa Pharmaceutical Peptides Services Forecast by Region (2023-2028)
10.5.1 Egypt Pharmaceutical Peptides Services Market Forecast
10.5.2 South Africa Pharmaceutical Peptides Services Market Forecast
10.5.3 Israel Pharmaceutical Peptides Services Market Forecast
10.5.4 Turkey Pharmaceutical Peptides Services Market Forecast
10.5.5 GCC Countries Pharmaceutical Peptides Services Market Forecast
10.6 Global Pharmaceutical Peptides Services Forecast by Type (2023-2028)
10.7 Global Pharmaceutical Peptides Services Forecast by Application (2023-2028)
11 KEY PLAYERS ANALYSIS
11.1 Creative Peptides
11.1.1 Creative Peptides Company Information
11.1.2 Creative Peptides Pharmaceutical Peptides Services Product Offered
11.1.3 Creative Peptides Pharmaceutical Peptides Services Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Creative Peptides Main Business Overview
11.1.5 Creative Peptides Latest Developments
11.2 AmbioPharm
11.2.1 AmbioPharm Company Information
11.2.2 AmbioPharm Pharmaceutical Peptides Services Product Offered
11.2.3 AmbioPharm Pharmaceutical Peptides Services Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 AmbioPharm Main Business Overview
11.2.5 AmbioPharm Latest Developments
11.3 3B Pharmaceuticals
11.3.1 3B Pharmaceuticals Company Information
11.3.2 3B Pharmaceuticals Pharmaceutical Peptides Services Product Offered
11.3.3 3B Pharmaceuticals Pharmaceutical Peptides Services Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 3B Pharmaceuticals Main Business Overview
11.3.5 3B Pharmaceuticals Latest Developments
11.4 ISSAR Pharma
11.4.1 ISSAR Pharma Company Information
11.4.2 ISSAR Pharma Pharmaceutical Peptides Services Product Offered
11.4.3 ISSAR Pharma Pharmaceutical Peptides Services Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 ISSAR Pharma Main Business Overview
11.4.5 ISSAR Pharma Latest Developments
11.5 Peptide Institute
11.5.1 Peptide Institute Company Information
11.5.2 Peptide Institute Pharmaceutical Peptides Services Product Offered
11.5.3 Peptide Institute Pharmaceutical Peptides Services Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Peptide Institute Main Business Overview
11.5.5 Peptide Institute Latest Developments
11.6 WuXi AppTec
11.6.1 WuXi AppTec Company Information
11.6.2 WuXi AppTec Pharmaceutical Peptides Services Product Offered
11.6.3 WuXi AppTec Pharmaceutical Peptides Services Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 WuXi AppTec Main Business Overview
11.6.5 WuXi AppTec Latest Developments
11.7 JPT Peptide Technologies
11.7.1 JPT Peptide Technologies Company Information
11.7.2 JPT Peptide Technologies Pharmaceutical Peptides Services Product Offered
11.7.3 JPT Peptide Technologies Pharmaceutical Peptides Services Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 JPT Peptide Technologies Main Business Overview
11.7.5 JPT Peptide Technologies Latest Developments
11.8 CPC Scientific
11.8.1 CPC Scientific Company Information
11.8.2 CPC Scientific Pharmaceutical Peptides Services Product Offered
11.8.3 CPC Scientific Pharmaceutical Peptides Services Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 CPC Scientific Main Business Overview
11.8.5 CPC Scientific Latest Developments
11.9 Red Glead Discovery
11.9.1 Red Glead Discovery Company Information
11.9.2 Red Glead Discovery Pharmaceutical Peptides Services Product Offered
11.9.3 Red Glead Discovery Pharmaceutical Peptides Services Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Red Glead Discovery Main Business Overview
11.9.5 Red Glead Discovery Latest Developments
11.10 Eurofins Scientific
11.10.1 Eurofins Scientific Company Information
11.10.2 Eurofins Scientific Pharmaceutical Peptides Services Product Offered
11.10.3 Eurofins Scientific Pharmaceutical Peptides Services Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Eurofins Scientific Main Business Overview
11.10.5 Eurofins Scientific Latest Developments
11.11 Bio-Synthesis
11.11.1 Bio-Synthesis Company Information
11.11.2 Bio-Synthesis Pharmaceutical Peptides Services Product Offered
11.11.3 Bio-Synthesis Pharmaceutical Peptides Services Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Bio-Synthesis Main Business Overview
11.11.5 Bio-Synthesis Latest Developments
11.12 Bio Basic
11.12.1 Bio Basic Company Information
11.12.2 Bio Basic Pharmaceutical Peptides Services Product Offered
11.12.3 Bio Basic Pharmaceutical Peptides Services Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Bio Basic Main Business Overview
11.12.5 Bio Basic Latest Developments
11.13 CordenPharma
11.13.1 CordenPharma Company Information
11.13.2 CordenPharma Pharmaceutical Peptides Services Product Offered
11.13.3 CordenPharma Pharmaceutical Peptides Services Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 CordenPharma Main Business Overview
11.13.5 CordenPharma Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Pharmaceutical Peptides Services Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Peptide Drug Discovery
Table 3. Major Players of Peptide Drug Bioconjugations
Table 4. Major Players of Peptide Lead Optimization
Table 5. Major Players of Formulation Development
Table 6. Major Players of Peptide Drug Screening Service
Table 7. Major Players of Total Peptide Library Construction Technology
Table 8. Major Players of Other
Table 9. Pharmaceutical Peptides Services Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 10. Global Pharmaceutical Peptides Services Market Size by Type (2017-2022) & ($ Millions)
Table 11. Global Pharmaceutical Peptides Services Market Size Market Share by Type (2017-2022)
Table 12. Pharmaceutical Peptides Services Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 13. Global Pharmaceutical Peptides Services Market Size by Application (2017-2022) & ($ Millions)
Table 14. Global Pharmaceutical Peptides Services Market Size Market Share by Application (2017-2022)
Table 15. Global Pharmaceutical Peptides Services Revenue by Players (2020-2022) & ($ Millions)
Table 16. Global Pharmaceutical Peptides Services Revenue Market Share by Player (2020-2022)
Table 17. Pharmaceutical Peptides Services Key Players Head office and Products Offered
Table 18. Pharmaceutical Peptides Services Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global Pharmaceutical Peptides Services Market Size by Regions 2017-2022 & ($ Millions)
Table 22. Global Pharmaceutical Peptides Services Market Size Market Share by Regions (2017-2022)
Table 23. Americas Pharmaceutical Peptides Services Market Size by Country (2017-2022) & ($ Millions)
Table 24. Americas Pharmaceutical Peptides Services Market Size Market Share by Country (2017-2022)
Table 25. Americas Pharmaceutical Peptides Services Market Size by Type (2017-2022) & ($ Millions)
Table 26. Americas Pharmaceutical Peptides Services Market Size Market Share by Type (2017-2022)
Table 27. Americas Pharmaceutical Peptides Services Market Size by Application (2017-2022) & ($ Millions)
Table 28. Americas Pharmaceutical Peptides Services Market Size Market Share by Application (2017-2022)
Table 29. APAC Pharmaceutical Peptides Services Market Size by Region (2017-2022) & ($ Millions)
Table 30. APAC Pharmaceutical Peptides Services Market Size Market Share by Region (2017-2022)
Table 31. APAC Pharmaceutical Peptides Services Market Size by Type (2017-2022) & ($ Millions)
Table 32. APAC Pharmaceutical Peptides Services Market Size Market Share by Type (2017-2022)
Table 33. APAC Pharmaceutical Peptides Services Market Size by Application (2017-2022) & ($ Millions)
Table 34. APAC Pharmaceutical Peptides Services Market Size Market Share by Application (2017-2022)
Table 35. Europe Pharmaceutical Peptides Services Market Size by Country (2017-2022) & ($ Millions)
Table 36. Europe Pharmaceutical Peptides Services Market Size Market Share by Country (2017-2022)
Table 37. Europe Pharmaceutical Peptides Services Market Size by Type (2017-2022) & ($ Millions)
Table 38. Europe Pharmaceutical Peptides Services Market Size Market Share by Type (2017-2022)
Table 39. Europe Pharmaceutical Peptides Services Market Size by Application (2017-2022) & ($ Millions)
Table 40. Europe Pharmaceutical Peptides Services Market Size Market Share by Application (2017-2022)
Table 41. Middle East & Africa Pharmaceutical Peptides Services Market Size by Region (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Pharmaceutical Peptides Services Market Size Market Share by Region (2017-2022)
Table 43. Middle East & Africa Pharmaceutical Peptides Services Market Size by Type (2017-2022) & ($ Millions)
Table 44. Middle East & Africa Pharmaceutical Peptides Services Market Size Market Share by Type (2017-2022)
Table 45. Middle East & Africa Pharmaceutical Peptides Services Market Size by Application (2017-2022) & ($ Millions)
Table 46. Middle East & Africa Pharmaceutical Peptides Services Market Size Market Share by Application (2017-2022)
Table 47. Key Market Drivers & Growth Opportunities of Pharmaceutical Peptides Services
Table 48. Key Market Challenges & Risks of Pharmaceutical Peptides Services
Table 49. Key Industry Trends of Pharmaceutical Peptides Services
Table 50. Global Pharmaceutical Peptides Services Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 51. Global Pharmaceutical Peptides Services Market Size Market Share Forecast by Regions (2023-2028)
Table 52. Global Pharmaceutical Peptides Services Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 53. Global Pharmaceutical Peptides Services Market Size Market Share Forecast by Type (2023-2028)
Table 54. Global Pharmaceutical Peptides Services Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 55. Global Pharmaceutical Peptides Services Market Size Market Share Forecast by Application (2023-2028)
Table 56. Creative Peptides Details, Company Type, Pharmaceutical Peptides Services Area Served and Its Competitors
Table 57. Creative Peptides Pharmaceutical Peptides Services Product Offered
Table 58. Creative Peptides Pharmaceutical Peptides Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 59. Creative Peptides Main Business
Table 60. Creative Peptides Latest Developments
Table 61. AmbioPharm Details, Company Type, Pharmaceutical Peptides Services Area Served and Its Competitors
Table 62. AmbioPharm Pharmaceutical Peptides Services Product Offered
Table 63. AmbioPharm Main Business
Table 64. AmbioPharm Pharmaceutical Peptides Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. AmbioPharm Latest Developments
Table 66. 3B Pharmaceuticals Details, Company Type, Pharmaceutical Peptides Services Area Served and Its Competitors
Table 67. 3B Pharmaceuticals Pharmaceutical Peptides Services Product Offered
Table 68. 3B Pharmaceuticals Main Business
Table 69. 3B Pharmaceuticals Pharmaceutical Peptides Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. 3B Pharmaceuticals Latest Developments
Table 71. ISSAR Pharma Details, Company Type, Pharmaceutical Peptides Services Area Served and Its Competitors
Table 72. ISSAR Pharma Pharmaceutical Peptides Services Product Offered
Table 73. ISSAR Pharma Main Business
Table 74. ISSAR Pharma Pharmaceutical Peptides Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. ISSAR Pharma Latest Developments
Table 76. Peptide Institute Details, Company Type, Pharmaceutical Peptides Services Area Served and Its Competitors
Table 77. Peptide Institute Pharmaceutical Peptides Services Product Offered
Table 78. Peptide Institute Main Business
Table 79. Peptide Institute Pharmaceutical Peptides Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Peptide Institute Latest Developments
Table 81. WuXi AppTec Details, Company Type, Pharmaceutical Peptides Services Area Served and Its Competitors
Table 82. WuXi AppTec Pharmaceutical Peptides Services Product Offered
Table 83. WuXi AppTec Main Business
Table 84. WuXi AppTec Pharmaceutical Peptides Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. WuXi AppTec Latest Developments
Table 86. JPT Peptide Technologies Details, Company Type, Pharmaceutical Peptides Services Area Served and Its Competitors
Table 87. JPT Peptide Technologies Pharmaceutical Peptides Services Product Offered
Table 88. JPT Peptide Technologies Main Business
Table 89. JPT Peptide Technologies Pharmaceutical Peptides Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. JPT Peptide Technologies Latest Developments
Table 91. CPC Scientific Details, Company Type, Pharmaceutical Peptides Services Area Served and Its Competitors
Table 92. CPC Scientific Pharmaceutical Peptides Services Product Offered
Table 93. CPC Scientific Main Business
Table 94. CPC Scientific Pharmaceutical Peptides Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. CPC Scientific Latest Developments
Table 96. Red Glead Discovery Details, Company Type, Pharmaceutical Peptides Services Area Served and Its Competitors
Table 97. Red Glead Discovery Pharmaceutical Peptides Services Product Offered
Table 98. Red Glead Discovery Main Business
Table 99. Red Glead Discovery Pharmaceutical Peptides Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. Red Glead Discovery Latest Developments
Table 101. Eurofins Scientific Details, Company Type, Pharmaceutical Peptides Services Area Served and Its Competitors
Table 102. Eurofins Scientific Pharmaceutical Peptides Services Product Offered
Table 103. Eurofins Scientific Main Business
Table 104. Eurofins Scientific Pharmaceutical Peptides Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 105. Eurofins Scientific Latest Developments
Table 106. Bio-Synthesis Details, Company Type, Pharmaceutical Peptides Services Area Served and Its Competitors
Table 107. Bio-Synthesis Pharmaceutical Peptides Services Product Offered
Table 108. Bio-Synthesis Pharmaceutical Peptides Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 109. Bio-Synthesis Main Business
Table 110. Bio-Synthesis Latest Developments
Table 111. Bio Basic Details, Company Type, Pharmaceutical Peptides Services Area Served and Its Competitors
Table 112. Bio Basic Pharmaceutical Peptides Services Product Offered
Table 113. Bio Basic Main Business
Table 114. Bio Basic Pharmaceutical Peptides Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 115. Bio Basic Latest Developments
Table 116. CordenPharma Details, Company Type, Pharmaceutical Peptides Services Area Served and Its Competitors
Table 117. CordenPharma Pharmaceutical Peptides Services Product Offered
Table 118. CordenPharma Main Business
Table 119. CordenPharma Pharmaceutical Peptides Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 120. CordenPharma Latest Developments
Table 1. Pharmaceutical Peptides Services Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Peptide Drug Discovery
Table 3. Major Players of Peptide Drug Bioconjugations
Table 4. Major Players of Peptide Lead Optimization
Table 5. Major Players of Formulation Development
Table 6. Major Players of Peptide Drug Screening Service
Table 7. Major Players of Total Peptide Library Construction Technology
Table 8. Major Players of Other
Table 9. Pharmaceutical Peptides Services Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 10. Global Pharmaceutical Peptides Services Market Size by Type (2017-2022) & ($ Millions)
Table 11. Global Pharmaceutical Peptides Services Market Size Market Share by Type (2017-2022)
Table 12. Pharmaceutical Peptides Services Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 13. Global Pharmaceutical Peptides Services Market Size by Application (2017-2022) & ($ Millions)
Table 14. Global Pharmaceutical Peptides Services Market Size Market Share by Application (2017-2022)
Table 15. Global Pharmaceutical Peptides Services Revenue by Players (2020-2022) & ($ Millions)
Table 16. Global Pharmaceutical Peptides Services Revenue Market Share by Player (2020-2022)
Table 17. Pharmaceutical Peptides Services Key Players Head office and Products Offered
Table 18. Pharmaceutical Peptides Services Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global Pharmaceutical Peptides Services Market Size by Regions 2017-2022 & ($ Millions)
Table 22. Global Pharmaceutical Peptides Services Market Size Market Share by Regions (2017-2022)
Table 23. Americas Pharmaceutical Peptides Services Market Size by Country (2017-2022) & ($ Millions)
Table 24. Americas Pharmaceutical Peptides Services Market Size Market Share by Country (2017-2022)
Table 25. Americas Pharmaceutical Peptides Services Market Size by Type (2017-2022) & ($ Millions)
Table 26. Americas Pharmaceutical Peptides Services Market Size Market Share by Type (2017-2022)
Table 27. Americas Pharmaceutical Peptides Services Market Size by Application (2017-2022) & ($ Millions)
Table 28. Americas Pharmaceutical Peptides Services Market Size Market Share by Application (2017-2022)
Table 29. APAC Pharmaceutical Peptides Services Market Size by Region (2017-2022) & ($ Millions)
Table 30. APAC Pharmaceutical Peptides Services Market Size Market Share by Region (2017-2022)
Table 31. APAC Pharmaceutical Peptides Services Market Size by Type (2017-2022) & ($ Millions)
Table 32. APAC Pharmaceutical Peptides Services Market Size Market Share by Type (2017-2022)
Table 33. APAC Pharmaceutical Peptides Services Market Size by Application (2017-2022) & ($ Millions)
Table 34. APAC Pharmaceutical Peptides Services Market Size Market Share by Application (2017-2022)
Table 35. Europe Pharmaceutical Peptides Services Market Size by Country (2017-2022) & ($ Millions)
Table 36. Europe Pharmaceutical Peptides Services Market Size Market Share by Country (2017-2022)
Table 37. Europe Pharmaceutical Peptides Services Market Size by Type (2017-2022) & ($ Millions)
Table 38. Europe Pharmaceutical Peptides Services Market Size Market Share by Type (2017-2022)
Table 39. Europe Pharmaceutical Peptides Services Market Size by Application (2017-2022) & ($ Millions)
Table 40. Europe Pharmaceutical Peptides Services Market Size Market Share by Application (2017-2022)
Table 41. Middle East & Africa Pharmaceutical Peptides Services Market Size by Region (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Pharmaceutical Peptides Services Market Size Market Share by Region (2017-2022)
Table 43. Middle East & Africa Pharmaceutical Peptides Services Market Size by Type (2017-2022) & ($ Millions)
Table 44. Middle East & Africa Pharmaceutical Peptides Services Market Size Market Share by Type (2017-2022)
Table 45. Middle East & Africa Pharmaceutical Peptides Services Market Size by Application (2017-2022) & ($ Millions)
Table 46. Middle East & Africa Pharmaceutical Peptides Services Market Size Market Share by Application (2017-2022)
Table 47. Key Market Drivers & Growth Opportunities of Pharmaceutical Peptides Services
Table 48. Key Market Challenges & Risks of Pharmaceutical Peptides Services
Table 49. Key Industry Trends of Pharmaceutical Peptides Services
Table 50. Global Pharmaceutical Peptides Services Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 51. Global Pharmaceutical Peptides Services Market Size Market Share Forecast by Regions (2023-2028)
Table 52. Global Pharmaceutical Peptides Services Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 53. Global Pharmaceutical Peptides Services Market Size Market Share Forecast by Type (2023-2028)
Table 54. Global Pharmaceutical Peptides Services Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 55. Global Pharmaceutical Peptides Services Market Size Market Share Forecast by Application (2023-2028)
Table 56. Creative Peptides Details, Company Type, Pharmaceutical Peptides Services Area Served and Its Competitors
Table 57. Creative Peptides Pharmaceutical Peptides Services Product Offered
Table 58. Creative Peptides Pharmaceutical Peptides Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 59. Creative Peptides Main Business
Table 60. Creative Peptides Latest Developments
Table 61. AmbioPharm Details, Company Type, Pharmaceutical Peptides Services Area Served and Its Competitors
Table 62. AmbioPharm Pharmaceutical Peptides Services Product Offered
Table 63. AmbioPharm Main Business
Table 64. AmbioPharm Pharmaceutical Peptides Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. AmbioPharm Latest Developments
Table 66. 3B Pharmaceuticals Details, Company Type, Pharmaceutical Peptides Services Area Served and Its Competitors
Table 67. 3B Pharmaceuticals Pharmaceutical Peptides Services Product Offered
Table 68. 3B Pharmaceuticals Main Business
Table 69. 3B Pharmaceuticals Pharmaceutical Peptides Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. 3B Pharmaceuticals Latest Developments
Table 71. ISSAR Pharma Details, Company Type, Pharmaceutical Peptides Services Area Served and Its Competitors
Table 72. ISSAR Pharma Pharmaceutical Peptides Services Product Offered
Table 73. ISSAR Pharma Main Business
Table 74. ISSAR Pharma Pharmaceutical Peptides Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. ISSAR Pharma Latest Developments
Table 76. Peptide Institute Details, Company Type, Pharmaceutical Peptides Services Area Served and Its Competitors
Table 77. Peptide Institute Pharmaceutical Peptides Services Product Offered
Table 78. Peptide Institute Main Business
Table 79. Peptide Institute Pharmaceutical Peptides Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Peptide Institute Latest Developments
Table 81. WuXi AppTec Details, Company Type, Pharmaceutical Peptides Services Area Served and Its Competitors
Table 82. WuXi AppTec Pharmaceutical Peptides Services Product Offered
Table 83. WuXi AppTec Main Business
Table 84. WuXi AppTec Pharmaceutical Peptides Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. WuXi AppTec Latest Developments
Table 86. JPT Peptide Technologies Details, Company Type, Pharmaceutical Peptides Services Area Served and Its Competitors
Table 87. JPT Peptide Technologies Pharmaceutical Peptides Services Product Offered
Table 88. JPT Peptide Technologies Main Business
Table 89. JPT Peptide Technologies Pharmaceutical Peptides Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. JPT Peptide Technologies Latest Developments
Table 91. CPC Scientific Details, Company Type, Pharmaceutical Peptides Services Area Served and Its Competitors
Table 92. CPC Scientific Pharmaceutical Peptides Services Product Offered
Table 93. CPC Scientific Main Business
Table 94. CPC Scientific Pharmaceutical Peptides Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. CPC Scientific Latest Developments
Table 96. Red Glead Discovery Details, Company Type, Pharmaceutical Peptides Services Area Served and Its Competitors
Table 97. Red Glead Discovery Pharmaceutical Peptides Services Product Offered
Table 98. Red Glead Discovery Main Business
Table 99. Red Glead Discovery Pharmaceutical Peptides Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. Red Glead Discovery Latest Developments
Table 101. Eurofins Scientific Details, Company Type, Pharmaceutical Peptides Services Area Served and Its Competitors
Table 102. Eurofins Scientific Pharmaceutical Peptides Services Product Offered
Table 103. Eurofins Scientific Main Business
Table 104. Eurofins Scientific Pharmaceutical Peptides Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 105. Eurofins Scientific Latest Developments
Table 106. Bio-Synthesis Details, Company Type, Pharmaceutical Peptides Services Area Served and Its Competitors
Table 107. Bio-Synthesis Pharmaceutical Peptides Services Product Offered
Table 108. Bio-Synthesis Pharmaceutical Peptides Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 109. Bio-Synthesis Main Business
Table 110. Bio-Synthesis Latest Developments
Table 111. Bio Basic Details, Company Type, Pharmaceutical Peptides Services Area Served and Its Competitors
Table 112. Bio Basic Pharmaceutical Peptides Services Product Offered
Table 113. Bio Basic Main Business
Table 114. Bio Basic Pharmaceutical Peptides Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 115. Bio Basic Latest Developments
Table 116. CordenPharma Details, Company Type, Pharmaceutical Peptides Services Area Served and Its Competitors
Table 117. CordenPharma Pharmaceutical Peptides Services Product Offered
Table 118. CordenPharma Main Business
Table 119. CordenPharma Pharmaceutical Peptides Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 120. CordenPharma Latest Developments
LIST OF FIGURES
LIST OF FIGURES
Figure 1. Pharmaceutical Peptides Services Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Pharmaceutical Peptides Services Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Pharmaceutical Peptides Services Market Size Market Share by Type in 2021
Figure 7. Pharmaceutical Peptides Services in Enterprise
Figure 8. Global Pharmaceutical Peptides Services Market: Enterprise (2017-2022) & ($ Millions)
Figure 9. Pharmaceutical Peptides Services in Research Institute
Figure 10. Global Pharmaceutical Peptides Services Market: Research Institute (2017-2022) & ($ Millions)
Figure 11. Global Pharmaceutical Peptides Services Market Size Market Share by Application in 2021
Figure 12. Global Pharmaceutical Peptides Services Revenue Market Share by Player in 2021
Figure 13. Global Pharmaceutical Peptides Services Market Size Market Share by Regions (2017-2022)
Figure 14. Americas Pharmaceutical Peptides Services Market Size 2017-2022 ($ Millions)
Figure 15. APAC Pharmaceutical Peptides Services Market Size 2017-2022 ($ Millions)
Figure 16. Europe Pharmaceutical Peptides Services Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa Pharmaceutical Peptides Services Market Size 2017-2022 ($ Millions)
Figure 18. Americas Pharmaceutical Peptides Services Value Market Share by Country in 2021
Figure 19. Americas Pharmaceutical Peptides Services Consumption Market Share by Type in 2021
Figure 20. Americas Pharmaceutical Peptides Services Market Size Market Share by Application in 2021
Figure 21. United States Pharmaceutical Peptides Services Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada Pharmaceutical Peptides Services Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico Pharmaceutical Peptides Services Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil Pharmaceutical Peptides Services Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC Pharmaceutical Peptides Services Market Size Market Share by Region in 2021
Figure 26. APAC Pharmaceutical Peptides Services Market Size Market Share by Application in 2021
Figure 27. China Pharmaceutical Peptides Services Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan Pharmaceutical Peptides Services Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea Pharmaceutical Peptides Services Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia Pharmaceutical Peptides Services Market Size Growth 2017-2022 ($ Millions)
Figure 31. India Pharmaceutical Peptides Services Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia Pharmaceutical Peptides Services Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe Pharmaceutical Peptides Services Market Size Market Share by Country in 2021
Figure 34. Europe Pharmaceutical Peptides Services Market Size Market Share by Type in 2021
Figure 35. Europe Pharmaceutical Peptides Services Market Size Market Share by Application in 2021
Figure 36. Germany Pharmaceutical Peptides Services Market Size Growth 2017-2022 ($ Millions)
Figure 37. France Pharmaceutical Peptides Services Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK Pharmaceutical Peptides Services Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy Pharmaceutical Peptides Services Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia Pharmaceutical Peptides Services Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Pharmaceutical Peptides Services Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa Pharmaceutical Peptides Services Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa Pharmaceutical Peptides Services Market Size Market Share by Application in 2021
Figure 44. Egypt Pharmaceutical Peptides Services Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa Pharmaceutical Peptides Services Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel Pharmaceutical Peptides Services Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey Pharmaceutical Peptides Services Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country Pharmaceutical Peptides Services Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas Pharmaceutical Peptides Services Market Size 2023-2028 ($ Millions)
Figure 50. APAC Pharmaceutical Peptides Services Market Size 2023-2028 ($ Millions)
Figure 51. Europe Pharmaceutical Peptides Services Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa Pharmaceutical Peptides Services Market Size 2023-2028 ($ Millions)
Figure 53. United States Pharmaceutical Peptides Services Market Size 2023-2028 ($ Millions)
Figure 54. Canada Pharmaceutical Peptides Services Market Size 2023-2028 ($ Millions)
Figure 55. Mexico Pharmaceutical Peptides Services Market Size 2023-2028 ($ Millions)
Figure 56. Brazil Pharmaceutical Peptides Services Market Size 2023-2028 ($ Millions)
Figure 57. China Pharmaceutical Peptides Services Market Size 2023-2028 ($ Millions)
Figure 58. Japan Pharmaceutical Peptides Services Market Size 2023-2028 ($ Millions)
Figure 59. Korea Pharmaceutical Peptides Services Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia Pharmaceutical Peptides Services Market Size 2023-2028 ($ Millions)
Figure 61. India Pharmaceutical Peptides Services Market Size 2023-2028 ($ Millions)
Figure 62. Australia Pharmaceutical Peptides Services Market Size 2023-2028 ($ Millions)
Figure 63. Germany Pharmaceutical Peptides Services Market Size 2023-2028 ($ Millions)
Figure 64. France Pharmaceutical Peptides Services Market Size 2023-2028 ($ Millions)
Figure 65. UK Pharmaceutical Peptides Services Market Size 2023-2028 ($ Millions)
Figure 66. Italy Pharmaceutical Peptides Services Market Size 2023-2028 ($ Millions)
Figure 67. Russia Pharmaceutical Peptides Services Market Size 2023-2028 ($ Millions)
Figure 68. Spain Pharmaceutical Peptides Services Market Size 2023-2028 ($ Millions)
Figure 69. Egypt Pharmaceutical Peptides Services Market Size 2023-2028 ($ Millions)
Figure 70. South Africa Pharmaceutical Peptides Services Market Size 2023-2028 ($ Millions)
Figure 71. Israel Pharmaceutical Peptides Services Market Size 2023-2028 ($ Millions)
Figure 72. Turkey Pharmaceutical Peptides Services Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries Pharmaceutical Peptides Services Market Size 2023-2028 ($ Millions)
LIST OF FIGURES
Figure 1. Pharmaceutical Peptides Services Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Pharmaceutical Peptides Services Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Pharmaceutical Peptides Services Market Size Market Share by Type in 2021
Figure 7. Pharmaceutical Peptides Services in Enterprise
Figure 8. Global Pharmaceutical Peptides Services Market: Enterprise (2017-2022) & ($ Millions)
Figure 9. Pharmaceutical Peptides Services in Research Institute
Figure 10. Global Pharmaceutical Peptides Services Market: Research Institute (2017-2022) & ($ Millions)
Figure 11. Global Pharmaceutical Peptides Services Market Size Market Share by Application in 2021
Figure 12. Global Pharmaceutical Peptides Services Revenue Market Share by Player in 2021
Figure 13. Global Pharmaceutical Peptides Services Market Size Market Share by Regions (2017-2022)
Figure 14. Americas Pharmaceutical Peptides Services Market Size 2017-2022 ($ Millions)
Figure 15. APAC Pharmaceutical Peptides Services Market Size 2017-2022 ($ Millions)
Figure 16. Europe Pharmaceutical Peptides Services Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa Pharmaceutical Peptides Services Market Size 2017-2022 ($ Millions)
Figure 18. Americas Pharmaceutical Peptides Services Value Market Share by Country in 2021
Figure 19. Americas Pharmaceutical Peptides Services Consumption Market Share by Type in 2021
Figure 20. Americas Pharmaceutical Peptides Services Market Size Market Share by Application in 2021
Figure 21. United States Pharmaceutical Peptides Services Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada Pharmaceutical Peptides Services Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico Pharmaceutical Peptides Services Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil Pharmaceutical Peptides Services Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC Pharmaceutical Peptides Services Market Size Market Share by Region in 2021
Figure 26. APAC Pharmaceutical Peptides Services Market Size Market Share by Application in 2021
Figure 27. China Pharmaceutical Peptides Services Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan Pharmaceutical Peptides Services Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea Pharmaceutical Peptides Services Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia Pharmaceutical Peptides Services Market Size Growth 2017-2022 ($ Millions)
Figure 31. India Pharmaceutical Peptides Services Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia Pharmaceutical Peptides Services Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe Pharmaceutical Peptides Services Market Size Market Share by Country in 2021
Figure 34. Europe Pharmaceutical Peptides Services Market Size Market Share by Type in 2021
Figure 35. Europe Pharmaceutical Peptides Services Market Size Market Share by Application in 2021
Figure 36. Germany Pharmaceutical Peptides Services Market Size Growth 2017-2022 ($ Millions)
Figure 37. France Pharmaceutical Peptides Services Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK Pharmaceutical Peptides Services Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy Pharmaceutical Peptides Services Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia Pharmaceutical Peptides Services Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Pharmaceutical Peptides Services Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa Pharmaceutical Peptides Services Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa Pharmaceutical Peptides Services Market Size Market Share by Application in 2021
Figure 44. Egypt Pharmaceutical Peptides Services Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa Pharmaceutical Peptides Services Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel Pharmaceutical Peptides Services Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey Pharmaceutical Peptides Services Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country Pharmaceutical Peptides Services Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas Pharmaceutical Peptides Services Market Size 2023-2028 ($ Millions)
Figure 50. APAC Pharmaceutical Peptides Services Market Size 2023-2028 ($ Millions)
Figure 51. Europe Pharmaceutical Peptides Services Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa Pharmaceutical Peptides Services Market Size 2023-2028 ($ Millions)
Figure 53. United States Pharmaceutical Peptides Services Market Size 2023-2028 ($ Millions)
Figure 54. Canada Pharmaceutical Peptides Services Market Size 2023-2028 ($ Millions)
Figure 55. Mexico Pharmaceutical Peptides Services Market Size 2023-2028 ($ Millions)
Figure 56. Brazil Pharmaceutical Peptides Services Market Size 2023-2028 ($ Millions)
Figure 57. China Pharmaceutical Peptides Services Market Size 2023-2028 ($ Millions)
Figure 58. Japan Pharmaceutical Peptides Services Market Size 2023-2028 ($ Millions)
Figure 59. Korea Pharmaceutical Peptides Services Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia Pharmaceutical Peptides Services Market Size 2023-2028 ($ Millions)
Figure 61. India Pharmaceutical Peptides Services Market Size 2023-2028 ($ Millions)
Figure 62. Australia Pharmaceutical Peptides Services Market Size 2023-2028 ($ Millions)
Figure 63. Germany Pharmaceutical Peptides Services Market Size 2023-2028 ($ Millions)
Figure 64. France Pharmaceutical Peptides Services Market Size 2023-2028 ($ Millions)
Figure 65. UK Pharmaceutical Peptides Services Market Size 2023-2028 ($ Millions)
Figure 66. Italy Pharmaceutical Peptides Services Market Size 2023-2028 ($ Millions)
Figure 67. Russia Pharmaceutical Peptides Services Market Size 2023-2028 ($ Millions)
Figure 68. Spain Pharmaceutical Peptides Services Market Size 2023-2028 ($ Millions)
Figure 69. Egypt Pharmaceutical Peptides Services Market Size 2023-2028 ($ Millions)
Figure 70. South Africa Pharmaceutical Peptides Services Market Size 2023-2028 ($ Millions)
Figure 71. Israel Pharmaceutical Peptides Services Market Size 2023-2028 ($ Millions)
Figure 72. Turkey Pharmaceutical Peptides Services Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries Pharmaceutical Peptides Services Market Size 2023-2028 ($ Millions)
